Journal decision profile

Tuberculosis and Respiratory Diseases

Medicine

Tuberculosis and Respiratory Diseases' 2026 Journal Metrics Score is 3.0, ranking Q1 in Epidemiology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

The Korean Academy of Tuberculosis and Respiratory DiseasesSouth KoreapISSN 1738-3536eISSN 2005-6184
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
3.0

Journal Metrics Score 2026 · 2021–2024 window citedness 3.15.

Review & acceptance time
i
Review & acceptance timeCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
106 daysmedian

Middle 50%: 72–163 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Tuberculosis and Respiratory Diseases accepts papers a median of 106 days after submission, including peer review and revisions. That is faster than 52% of comparable journals with PubMed timing data.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

Free preview · no sign-in

Does your manuscript fit Tuberculosis and Respiratory Diseases?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
3.02026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#164 / 4,177LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
13%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.83MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
106 daysIQR 72–163 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
48 / yr2021–2024 AVG
Field-normalized top 10% share13%

25 of 192 works · same type, year & subfield

Field-normalized top 1% share0.5%

1 works · same type, year & subfield

Median FWCI0.83×

Below field-year expectation

Source output rank#164

of 4,177 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.83, so its typical recent paper runs about 17% below its field benchmark.

What does Top 10% Share mean?

13% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

432016
602017
662018
342019
582020
522021
372022
442023
602024
802025

Recent work-type mix

192 OpenAlex works · 2021–2024

Article93.8%
Review6.3%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and research coverage

OpenAlex topics show the research communities this journal serves.

Leading OpenAlex topics

2021–2024 works
Chronic Obstructive Pulmonary Disease (COPD) Research38
Tuberculosis Research and Epidemiology28
COVID-19 Clinical Research Studies18
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis12
Asthma and respiratory diseases9
Lung Cancer Diagnosis and Treatment8
Respiratory Support and Mechanisms7
Cystic Fibrosis Research Advances6
Mycobacterium research and diagnosis6
Lung Cancer Treatments and Mutations4
Methodology: OpenAlex snapshot 2026-10-16. FWCI, percentile badges, topics, and type mix use 192 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Infectious DiseasesQ2
EpidemiologyQ1
Pulmonary and Respiratory MedicineQ1

Is Tuberculosis and Respiratory Diseases a good journal?

Yes. A Q1 journal by citation data

Yes. By citation data, Tuberculosis and Respiratory Diseases is a strong journal: it is Q1 in Epidemiology and 1 other subfield and ranks #1,448 of 6,272 Medicine journals by Journal Metrics Score (top 24%). Tuberculosis and Respiratory Diseases' 2026 Journal Metrics Score is 3.0. Recent papers took a median of 106 days from submission to acceptance, according to PubMed dates. OpenAlex classifies its papers in subfields including Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine, so check that your topic fits its scope.

Best quartile
Q1
Epidemiology
Rank in Medicine
#1,448 of 6,272
Top 24%
2026 Journal Metrics Score
3.0
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
106 days
Median, PubMed records
Access model
Fully open access
No APC on record in OpenAlex
Papers published in 2025
80
OpenAlex works

Check before you submit

  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q1
Subfield Quartile
N/A
CAS Block

Ranking and source check

#1,448
of 6,272 Medicine field journals
#1,418
among Q1 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
4,872
H-Index
46
Fully Open Access
Yes
Recent OA Works
4,316
Subject Areas
Infectious DiseasesEpidemiologyPulmonary and Respiratory Medicine

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Tuberculosis and Respiratory Diseases

  1. 1

    Check the scope

    OpenAlex classifies Tuberculosis and Respiratory Diseases' papers in subfields including Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Tuberculosis and Respiratory Diseases homepage ↗
  3. 3

    Submit online

    Use the submit link in Tuberculosis and Respiratory Diseases' author guidelines; The Korean Academy of Tuberculosis and Respiratory Diseases runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    The journal is fully open access, and OpenAlex has no article processing charge on record. Check the journal website for current fees and waivers.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 106 days from submission to acceptance, including revisions (PubMed dates). Tuberculosis and Respiratory Diseases does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Tuberculosis and Respiratory Diseases

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Tuberculosis and Respiratory Diseases

Is Tuberculosis and Respiratory Diseases a good journal?

Yes. By citation data, Tuberculosis and Respiratory Diseases is a strong journal: it is Q1 in Epidemiology and 1 other subfield and ranks #1,448 of 6,272 Medicine journals by Journal Metrics Score (top 24%). Tuberculosis and Respiratory Diseases' 2026 Journal Metrics Score is 3.0. Recent papers took a median of 106 days from submission to acceptance, according to PubMed dates. OpenAlex classifies its papers in subfields including Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine, so check that your topic fits its scope.

What is Tuberculosis and Respiratory Diseases' Journal Metrics Score in 2026?

Tuberculosis and Respiratory Diseases' 2026 Journal Metrics Score is 3.0, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Tuberculosis and Respiratory Diseases?

We have not found an official acceptance rate published by Tuberculosis and Respiratory Diseases or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 106 days from submission to acceptance. To judge selectivity, compare Tuberculosis and Respiratory Diseases' quartile and score with similar journals, or ask the editorial office.

What quartile is Tuberculosis and Respiratory Diseases in?

Tuberculosis and Respiratory Diseases' best quartile is Q1. By OpenAlex subfield: Q2 in Infectious Diseases; Q1 in Epidemiology; Q1 in Pulmonary and Respiratory Medicine. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Tuberculosis and Respiratory Diseases will not match this score exactly. Compare journals using one source at a time.

How long does Tuberculosis and Respiratory Diseases take to accept a paper?

Tuberculosis and Respiratory Diseases accepts papers a median of 106 days after submission across 100 recent PubMed records with both dates; the middle half took 72–163 days. This includes peer review, editorial handling, and revisions.

How long is the peer review time at Tuberculosis and Respiratory Diseases?

PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Tuberculosis and Respiratory Diseases, which includes peer review and revisions, has a median of 106 days. For the time to a first decision, check the journal's own website.

Is Tuberculosis and Respiratory Diseases faster than similar journals?

Tuberculosis and Respiratory Diseases' median of 106 days from submission to acceptance is faster than 52% of comparable journals with PubMed timing data.

Which journals are alternatives to Tuberculosis and Respiratory Diseases?

Comparable journals include Jornal Brasileiro De Pneumologia, Lung India, Lancet Respiratory Medicine, and European Respiratory Review. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Tuberculosis and Respiratory Diseases?

Submit online through the link in Tuberculosis and Respiratory Diseases' author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 106 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search